Evidence map›Paper›PMID 23533314›Full record

ArticleMediators of inflammation2013

Serum IL-12 is increased in Mexican obese subjects and associated with low-grade inflammation and obesity-related parameters.

K Suárez-Álvarez, L Solís-Lozano, S Leon-Cabrera, A González-Chávez, G Gómez-Hernández, M S Quiñones-Álvarez, A E Serralde-Zúñiga, J Hernández-Ruiz, J Ramírez-Velásquez, F J Galindo-González and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03703141 (Effect of Acute or Chronic Ingestion of Sucralose on Serum Insulin in Young and Healthy Adults), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03703141 nacompletednot on this mapstarted 2016, after this paper: background citation

Effect of Acute or Chronic Ingestion of Sucralose on Serum Insulin in Young and Healthy Adults: a Randomized, Double-blind, Placebo-controlled Trial

TypeinterventionalSponsorHospital General de México Dr. Eduardo LiceagaRan2016 to 2018Enrolled95ConditionsHealthyArmssucralose 48 mg (splenda)/day for ten weeks
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Review
  12. Innate Lymphoid Cell Immunometabolism.Journal of molecular biology · 2017
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. HIF-2: the missing link between obesity and cardiomyopathy.Journal of the American Heart Association · 2013
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

K Suárez-ÁlvarezUnidad de Medicina Experimental, Hospital General de México, Dr. Eduardo Liceaga, México D. F. 06726, Mexico.
L Solís-Lozano
S Leon-Cabrera
A González-Chávez
G Gómez-Hernández
M S Quiñones-Álvarez
A E Serralde-Zúñiga
J Hernández-Ruiz
J Ramírez-Velásquez
F J Galindo-González
J C Zavala-Castillo
M A De León-Nava
G Robles-Díaz
G Escobedo
Hospital General de México · MXUniversidad Nacional Autónoma de México · MXCenter for Scientific Research and Higher Education at Ensenada · MXMexfam · MXUniversidad Autónoma Metropolitana · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-(IL-) 12 has been recently suggested to participate during development of insulin resistance in obese mice. Nevertheless, serum IL-12 levels have not been accurately determined in overweight and obese humans. We thus studied serum concentrations of IL-12 in Mexican adult individuals, examining their relationship with low-grade inflammation and obesity-related parameters. A total of 147 healthy individuals, 43 normal weight, 61 overweight, and 43 obese subjects participated in the study. Circulating levels of IL-12, tumor necrosis factor-alpha (TNF- α ), leptin, insulin, glucose, total cholesterol, and triglyceride were measured after overnight fasting in all of the study subjects. Waist circumference and body fat percentage were recorded for all the participants. Serum IL-12 was significantly higher in overweight and obese individuals than in normal weight controls. Besides being strongly related with body mass index (r = 0.5154), serum IL-12 exhibited a significant relationship with abdominal obesity (r = 0.4481), body fat percentage (r = 0.5625), serum glucose (r = 0.3158), triglyceride (r = 0.3714), and TNF- α (r = 0.4717). Thus, serum levels of IL-12 are increased in overweight and obese individuals and show a strong relationship with markers of low-grade inflammation and obesity in the Mexican adult population. Further research is needed to understand the role of IL-12 in developing obesity-associated alterations in humans.

Indexed as

AdultFemaleHumansInflammationInsulinInterleukin-12LeptinMaleObesityTriglyceridesTumor Necrosis Factor-alphaYoung AdultInsulinInterleukin-12LeptinTriglyceridesTumor Necrosis Factor-alpha

Identifiers

PMID23533314
PMCPMC3590791
OpenAlexW1965779127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.